Flecainide and Alcohol/Food Interactions
There is 1 alcohol/food/lifestyle interaction with flecainide.
Flecainide Nicotine
Moderate Drug Interaction
Consumer information for this interaction is not currently available.
MONITOR: Smoking cessation may lead to elevated plasma concentrations and enhanced pharmacologic effects of drugs that are substrates of CYP450 1A2 (and possibly CYP450 1A1) and/or certain drugs with a narrow therapeutic index (e.g., flecainide, pentazocine). One proposed mechanism is related to the loss of CYP450 1A2 and 1A1 induction by polycyclic aromatic hydrocarbons in tobacco smoke; when smoking cessation agents are initiated and smoking stops, the metabolism of certain drugs may decrease leading to increased plasma concentrations. The mechanism by which smoking cessation affects narrow therapeutic index drugs that are not known substrates of CYP450 1A2 or 1A1 is unknown. The clinical significance of this interaction is unknown as clinical data are lacking.
MANAGEMENT: Until more information is available, caution is advisable if smoking cessation agents are used concomitantly with drugs that are substrates of CYP450 1A2 or 1A1 and/or those with a narrow therapeutic range. Patients receiving smoking cessation agents may require periodic dose adjustments and closer clinical and laboratory monitoring of medications that are substrates of CYP450 1A2 or 1A1.
Switch to professional interaction data
Flecainide drug interactions
There are 368 drug interactions with flecainide.
Flecainide disease interactions
There are 5 disease interactions with flecainide which include:
- cardiovascular dysfunction
- sinus-AV node dysfunction
- electrolyte imbalance
- hepatic dysfunction
- renal dysfunction
More about flecainide
- flecainide consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (176)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- Drug class: group I antiarrhythmics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Xarelto
Xarelto (rivaroxaban) is a factor Xa inhibitor used to reduce the risk of blood clots and stroke in ...
Cardizem
Cardizem is used to treat hypertension (high blood pressure), angina (chest pain), and heart rhythm ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Propafenone
Propafenone systemic is used for atrial fibrillation, atrial flutter, ventricular tachycardia ...
Phenylephrine
Oral and nasal phenylephrine are used as nasal decongestants to temporarily unblock a nose or ...
Sotalol
Sotalol is a beta-blocker with antiarrhythmic properties that affects the heart and circulation ...
Rivaroxaban
Rivaroxaban systemic is used for atrial fibrillation, cardiovascular risk reduction, congenital ...
Bisoprolol
Bisoprolol belongs to a group of drugs called beta-blockers and is used to treat hypertension (high ...
Digoxin
Digoxin is used to treat congestive heart failure and to slow the heart rate in patients with ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.